A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00977561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open Label Study Of Figitumumab (CP-751,871) Plus Cisplatin (Or Carboplatin) And Etoposide, Versus Cisplatin (Or Carboplatin) And Etoposide Alone, As First Line Treatment In Patients With Extensive Stage Disease Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00977561
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 9 participants
Conditions and interventions
Conditions
Interventions
- Cisplatin (Or Carboplatin) Drug
- Etoposide Drug
- figitumumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2010
- Primary completion
- Sep 30, 2011
- Completion
- Sep 30, 2011
- Last update posted
- Feb 24, 2013
2010 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 9
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20007-2197 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20007 | — |
| Pfizer Investigational Site | Marrero | Louisiana | 70072 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70006 | — |
| Pfizer Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| Pfizer Investigational Site | Creve Coeur | Missouri | 63141 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110-1094 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110 | — |
| Pfizer Investigational Site | Morristown | New Jersey | 07962 | — |
| Pfizer Investigational Site | Hickory | North Carolina | 28602 | — |
| Pfizer Investigational Site | Kernersville | North Carolina | 27284 | — |
| Pfizer Investigational Site | Lenoir | North Carolina | 28645 | — |
| Pfizer Investigational Site | Lexington | North Carolina | 27295 | — |
| Pfizer Investigational Site | Mount Airy | North Carolina | 27030 | — |
| Pfizer Investigational Site | North Wilkesboro | North Carolina | 28659 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Beaverton | Oregon | 97006 | — |
| Pfizer Investigational Site | Gresham | Oregon | 97030 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Portland | Oregon | 97239 | — |
| Pfizer Investigational Site | Tualatin | Oregon | 97062 | — |
| Pfizer Investigational Site | West Reading | Pennsylvania | 19611 | — |
| Pfizer Investigational Site | Christiansburg | Virginia | 24074 | — |
| Pfizer Investigational Site | Low Moor | Virginia | 24457 | — |
| Pfizer Investigational Site | Roanoke | Virginia | 24014 | — |
| Pfizer Investigational Site | Salem | Virginia | 24153 | — |
| Pfizer Investigational Site | Wytheville | Virginia | 24382 | — |
| Pfizer Investigational Site | Everett | Washington | 98201 | — |
| Pfizer Investigational Site | Federal Way | Washington | 98003 | — |
| Pfizer Investigational Site | Gig Harbor | Washington | 98332 | — |
| Pfizer Investigational Site | Kennewick | Washington | 99336 | — |
| Pfizer Investigational Site | Lakewood | Washington | 98499 | — |
| Pfizer Investigational Site | Puyallup | Washington | 98372 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00977561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2013 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00977561 live on ClinicalTrials.gov.